Former life sciences and analytical instruments business units integrated into a new 'life and analytical sciences' organisation
PerkinElmer has announced the combination of its Life Sciences and Analytical Instruments business units into a new integrated business named Life and Analytical Sciences.
The new business will leverage the strengths of the respective sales, service, and R and D organisations along with operational scale to better serve customers.
Peter Coggins, formerly president of PerkinElmer Life Sciences, will serve as president of the new organisation, effective immediately.
The new organisation has approximately $1 billion in revenue, more than 2000 sales, service and applications support personnel, and an annual R and D budget of $65 million.
"An integrated Life and Analytical Sciences organisation will enable PerkinElmer to provide a single, unified face to our customers in the biopharmaceutical and clinical diagnostics markets, as well as bring greater resources to our analytical customers," said Gregory Summe, chairman and CEO of PerkinElmer.
"It also enables us to better leverage our R and D investment, global sales and service network, and operational capabilities.
This simpler, more streamlined structure is consistent with our strategy of developing a cost-effective, customer-oriented and innovative organisation, and is an important step in growing our health sciences businesses.
Peter Coggins brings 29 years of health sciences experience, exceptional leadership skills, and a strong customer focus, making him the ideal candidate to lead the new Life and Analytical Sciences team." Stephen DeFalco, the current president of Analytical Instruments, will assist in the transition through the end of the year.
The new organisation will be headquartered in Boston, and the company will continue to maintain a significant presence in Shelton, Connecticut, formerly headquarters of the Analytical Instruments business unit.
